Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2021/22 parent results

May 13 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             10.03           4.20                                 
                (+138.9 pct)     (-30.1 pct)                             
  Operating          8.36           2.49                                 
                (+235.7 pct)     (-39.8 pct)                             
  Recurring          8.26           2.47                                 
                (+235.0 pct)     (-39.5 pct)                             
  Net               10.69           1.87                                 
                (+472.1 pct)     (-39.7 pct)                             
  EPS            131.16 yen       23.40 yen                              
  EPS Diluted    131.01 yen       23.37 yen                              
  Ann Div        100.00 yen      100.00 yen     100.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         50.00 yen       50.00 yen      50.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news